- Professor, CWRU School of Medicine
- Cardiac Tumors
- Stress Echocardiography
- Three Dimensional Echocardiography
- Transesophageal Echocardiography
- Two-Dimensional and Color Doppler Echocardiography
Patient Satisfaction Reviews
4.7 out of 5
Patient Comments (9)
Reviewed On 2/22/2020
Doctor Thomas King is my Doctor I just cannot say enough good about himHe listens to me Knows exactly what is the matter with me He is very knowledge and very very kind I was sick several times these last few moths I did nnot have to wait for an appointment He saw me the same day That is very imporant when you do not feel
Reviewed On 2/15/2020
Excellent office visit like all of the previous office visits with Doctor Farah.
Reviewed On 1/23/2020
Reviewed On 11/23/2019
Reviewed On 11/18/2019
Reviewed On 10/27/2019
Short, sweet, and simple, just the way I like it.
Reviewed On 10/20/2019
I'm always happy to see Dr. Farah. He is extremely knowledgeable, explains things well and is polite and kind.
Reviewed On 10/4/2019
Reviewed On 10/3/2019
helpful and friendly. [...]
- Cardiovascular Disease - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Fellowship | Cardiovascular Disease
Cardiovascular Disease - University Hospitals Of Cleveland (1974 - 1975)
Residency | Cardiovascular Disease
Cardiovascular Disease - University Hospitals Of Cleveland (1972 - 1974)
Residency | Internal Medicine
Internal Medicine - American University Of Beirut (1970 - 1972)
Internship | Internal Medicine
Internal Medicine - American University Of Beirut (1969 - 1970)
American University Of Beirut (1970)
American University Of Beirut (1966)
Birzeit University (1964)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Michel Farah did not disclose any Outside Relationships with Industry.